Changes in Influenza Activity and Circulating Subtypes During the COVID-19 Outbreak in China

Non-pharmaceutical interventions (NPIs) to mitigate COVID-19 can impact the circulation of influenza viruses. There is a need to describe the activity of influenza and its subtypes during the COVID-19 pandemic to aid in the development of influenza prevention and control measures in the next influen...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in medicine Vol. 9; p. 829799
Main Authors Zheng, Luyan, Qi, Jinjin, Wu, Jie, Zheng, Min
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 22.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Non-pharmaceutical interventions (NPIs) to mitigate COVID-19 can impact the circulation of influenza viruses. There is a need to describe the activity of influenza and its subtypes during the COVID-19 pandemic to aid in the development of influenza prevention and control measures in the next influenza season. Data from pathogenic surveillance performed by the Chinese National Influenza Center from January 2016 to August 2021 were extracted and stratified by type and subtype for northern China and southern China. The distribution of influenza activity and circulating subtypes were described during the COVID-19 pandemic, and data from 2016 to 2019 were used for comparisons. Influenza activity declined rapidly and then rose slowly during the COVID-19 pandemic in China. The distribution of influenza subtypes changed from A-dominant to B/Victoria-dominant after the COVID-19 outbreak. Whether the B/Yamagata lineage has disappeared from China deserves more attention in future virologic monitoring programs. The influenza vaccination campaign in the 2021-2022 season is an important means by which to reduce the proportion of susceptible people and limit the damage that potentially greater and earlier circulation of the virus could cause.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Piero Valentini, Unit of Pediatrics, Department of Women’s Health, Children’s Health and Public Health, Agostino Gemelli University Polyclinic (IRCCS), Italy
Reviewed by: Shobha Broor, Shree Guru Gobind Singh Tricentenary University, India
This article was submitted to Infectious Diseases – Surveillance, Prevention and Treatment, a section of the journal Frontiers in Medicine
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2022.829799